American Medical Association

SHERPA: White

People

  1. Marghoob
    Marghoob
  2. Halpern
    Halpern
  3. Morrow
    Morrow
  4. Busam
    Busam
  5. Abramson
    Abramson
  6. Brennan
    Brennan
  7. Offit
    Offit
  8. Coit
    Coit
  9. Morris
    Morris
  10. Lee
    Lee

Groups

  1. Department of Medicine (483)
  2. Survivorship Research (357)
  3. Surgery (347)
  4. Population Sciences Research Program (290)
  5. Solid Tumor Oncology Division (233)
  6. Division of Subspecialty Medicine (222)
  7. Epidemiology and Biostatistics (172)
  8. Dermatology (169)
  9. Dermatology Service (168)
  10. Melanoma Disease Management Team (128)
Search Within
Formats
  1. Journal Article (916)
  2. Editorial (89)
  3. Correspondence (56)
  4. Review (39)
  5. Research Letter (37)
  6. Conference Paper (9)
  7. Guidelines (9)
  8. Miscellaneous (6)
Groups
  1. Department of Medicine (483)
  2. Survivorship Research (357)
  3. Surgery (347)
  4. Population Sciences Research Program (290)
  5. Solid Tumor Oncology Division (233)
  6. Division of Subspecialty Medicine (222)

More Groups

People
  1. Ashfaq Marghoob (89)
  2. Allan Halpern (50)
  3. Monica Morrow (46)
  4. Peter Bach (39)
  5. Klaus Busam (35)
  6. David Abramson (33)

More People

Years
  1. 2025 (30)
  2. 2024 (69)
  3. 2023 (63)
  4. 2022 (56)
  5. 2021 (75)
  6. 2020 (72)

More Years

Publications
  1. JAMA Oncology (321)
  2. JAMA - Journal of the American Medical Association (246)
  3. JAMA Dermatology (110)
  4. Archives of Dermatology (86)
  5. JAMA Surgery (77)
  6. Archives of Surgery (73)

More Publications

Results (1161)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Recurrence after resection of pancreatic ductal adenocarcinoma
    Correspondence

    Williams, T. M.; Crane, C.; Goodman, K.
    JAMA Surgery (2020)

    Fulltext@MSK | Save
  • Co-occurrence of Merkel cell carcinoma and chronic inflammatory demyelinating polyneuropathy
    Correspondence

    Kuo, A. M. S.; Barker, C. A.
    JAMA Dermatology (2020)

    Fulltext@MSK | Save
  • Facial erythema in an elderly man
    Miscellaneous

    Navarrete-Dechent, C.; Busam, K. J.; Markova, A.
    JAMA Dermatology (2020)

    Fulltext@MSK | Save
  • HSD3B1 genotype and clinical outcomes in metastatic castration-sensitive prostate cancer
    Journal Article

    Hearn, J. W. D.; Sweeney, C. J.; Almassi, N.; Reichard, C. A.; Reddy, C. A.; Li, H.; Hobbs, B.; Jarrard, D. F.; Chen, Y. H.; Dreicer, R.; more...
    JAMA Oncology (2020)

    Fulltext@MSK | Save
  • Stereotactic ablative radiotherapy for the management of spinal metastases: A review
    Review

    Glicksman, R. M.; Tjong, M. C.; Neves-Junior, W. F. P.; Spratt, D. E.; Chua, K. L. M.; Mansouri, A.; Chua, M. L. K.; Berlin, A.; Winter, J. D.; Dahele, M.; more...
    JAMA Oncology (2020)

    Fulltext@MSK | Save
  • Surveillance outcomes and intensity of salvage therapy among human papillomavirus-associated oropharyngeal cancers
    Correspondence

    Arvold, N. D.; McBride, S. M.
    JAMA Otolaryngology - Head and Neck Surgery (2020)

    Fulltext@MSK | Save
  • Effect of doxorubicin plus olaratumab vs doxorubicin plus placebo on survival in patients with advanced soft tissue sarcomas: The ANNOUNCE randomized clinical trial
    Journal Article

    Tap, W. D.; Wagner, A. J.; Schöffski, P.; Martin-Broto, J.; Krarup-Hansen, A.; Ganjoo, K. N.; Yen, C. C.; Abdul Razak, A. R.; Spira, A.; Kawai, A.; more...
    JAMA - Journal of the American Medical Association (2020)

    Fulltext@MSK | Save
  • Clinician vs patient reporting of baseline and postbaseline symptoms for adverse event assessment in cancer clinical trials
    Research Letter

    Atkinson, T. M.; Dueck, A. C.; Satele, D. V.; Thanarajasingam, G.; Lafky, J. M.; Sloan, J. A.; Basch, E.
    JAMA Oncology (2020)

    Fulltext@MSK | Save
  • Moving from cancer burden to cancer genomics for smoldering myeloma: A review
    Review

    Maura, F.; Bolli, N.; Rustad, E. H.; Hultcrantz, M.; Munshi, N.; Landgren, O.
    JAMA Oncology (2020)

    Fulltext@MSK | Save
  • Assessment of adverse events from the patient perspective in a phase 3 metastatic castration-resistant prostate cancer clinical trial
    Journal Article

    Dueck, A. C.; Scher, H. I.; Bennett, A. V.; Mazza, G. L.; Thanarajasingam, G.; Schwab, G.; Weitzman, A. L.; Rogak, L. J.; Basch, E.
    JAMA Oncology (2020)

    Fulltext@MSK | Save